Recurrent gene fusions are common in high-grade serous ovarian cancer.

被引：0
|
作者：
Lehtonen, Rainer [1 ]
Carpen, Olli [1 ]
Huhtinen, Kaisa [2 ]
Hynninen, Johanna [2 ]
Kaipio, Katja [2 ]
Lamminen, Tarja [2 ]
Cervera, Alejandra [1 ]
Hietanen, Sakari [2 ]
Grenman, Seija [2 ]
Hautaniemi, Sampsa [1 ]
机构：
[1] Univ Helsinki, Helsinki, Finland
[2] Univ Turku, Turku, Finland
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B48
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [41] Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
    Elizabeth L. Christie
    Swetansu Pattnaik
    Jessica Beach
    Anthony Copeland
    Nineveh Rashoo
    Sian Fereday
    Joy Hendley
    Kathryn Alsop
    Samuel L. Brady
    Greg Lamb
    Ahwan Pandey
    Anna deFazio
    Heather Thorne
    Andrea Bild
    David D. L. Bowtell
    Nature Communications, 10
  • [42] Principles of dormancy evident in high-grade serous ovarian cancer
    Trevor G. Shepherd
    Frederick A. Dick
    Cell Division, 17
  • [43] The peritoneal tumour microenvironment of high-grade serous ovarian cancer
    Leinster, D. Andrew
    Kulbe, Hagen
    Everitt, Gemma
    Thompson, Richard
    Perretti, Mauro
    Gavins, Felicity N. E.
    Cooper, Dianne
    Gould, David
    Ennis, Darren P.
    Lockley, Michelle
    McNeish, Iain A.
    Nourshargh, Sussan
    Balkwill, Frances R.
    JOURNAL OF PATHOLOGY, 2012, 227 (02): : 136 - 145
  • [44] Centrosomes - The Achilles' heel of high-grade serous ovarian cancer?
    Chandrasekaran, G.
    Hall, D.
    Vias, M.
    Brenton, J. D.
    Gergely, F.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [45] Determinants of resistance and response in high-grade serous ovarian cancer
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [46] Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
    Freimund, Alison E.
    Beach, Jessica A.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 983 - +
  • [47] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12): : 1169 - 1174
  • [48] Tumor immunogenicity status in high-grade serous ovarian cancer
    Berry, Laurel
    Kelly, Michael
    Miller, Lance
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S319 - S319
  • [49] Novel strategies for targeting high-grade serous ovarian cancer
    Perets, Ruth
    Wyant, Gregory A.
    Ohman, Anders W.
    Setlur, Sunita R.
    Crum, Christopher P.
    Drapkin, Ronny
    Dinulescu, Daniela M.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [50] Describing intratumoural heterogeneity in high-grade serous ovarian cancer
    Nixon, K.
    Wulandari, R.
    Curry, E.
    Rama, N.
    Bowtell, D.
    Cunnea, P.
    Fotopoulou, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 87 - 88
12345